Raymond W. Lam
#127,612
Most Influential Person Now
Researcher
Raymond W. Lam's AcademicInfluence.com Rankings
Raymond W. Lamengineering Degrees
Engineering
#4250
World Rank
#5435
Historical Rank
Electrical Engineering
#1063
World Rank
#1144
Historical Rank
Raymond W. Lamcomputer-science Degrees
Computer Science
#5443
World Rank
#5751
Historical Rank
Computational Linguistics
#761
World Rank
#774
Historical Rank
Machine Learning
#1453
World Rank
#1475
Historical Rank
Artificial Intelligence
#1685
World Rank
#1717
Historical Rank
Download Badge
Engineering Computer Science
Raymond W. Lam's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Computer Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Raymond W. Lam Influential?
(Suggest an Edit or Addition)Raymond W. Lam's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (2018) (891)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) (536)
- Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial (2018) (514)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction. (2009) (509)
- The interpersonal expression of perfection: perfectionistic self-presentation and psychological distress. (2003) (404)
- Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. (2009) (402)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. (2009) (380)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) (375)
- Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial. (2017) (321)
- A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes (2014) (317)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) (317)
- Antidepressant effects of exercise: evidence for an adult-neurogenesis hypothesis? (2006) (316)
- A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. (2012) (305)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management. (2009) (266)
- Cognitive Dysfunction in Major Depressive Disorder: Effects on Psychosocial Functioning and Implications for Treatment (2014) (259)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) (258)
- Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: A Systematic Review and Metaanalysis (2008) (250)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) (243)
- Quality of life in bipolar disorder: A review of the literature (2005) (239)
- The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. (2006) (238)
- Bipolar Disorder and Quality of Life: A Patient-Centered Perspective (2006) (236)
- Chronotherapeutics (light and wake therapy) in affective disorders (2005) (233)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) (225)
- Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis. (2006) (219)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. (2009) (212)
- Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments. (2001) (211)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments. (2009) (209)
- Pathophysiology of seasonal affective disorder: a review. (2000) (189)
- Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta‐analysis (2012) (187)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication. (2009) (186)
- Efficacy of Bright Light Treatment, Fluoxetine, and the Combination in Patients With Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial. (2016) (169)
- Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy. (1996) (168)
- Brain serotonin2 receptors in major depression: a positron emission tomography study. (2000) (160)
- Which antidepressants have demonstrated superior efficacy? A review of the evidence (2007) (160)
- The relationship between neurocognitive and psychosocial functioning in major depressive disorder: a systematic review. (2014) (155)
- Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone. (1999) (146)
- Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode. (2010) (142)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) (141)
- The impact of bipolar disorder upon work functioning: a qualitative analysis. (2007) (139)
- MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes (2017) (131)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments. (2018) (131)
- Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. (1995) (128)
- Combining antidepressants for treatment-resistant depression: a review. (2002) (123)
- PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium. (2002) (119)
- Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis. (2008) (117)
- Seasonal affective disorder: a clinical update. (2007) (113)
- The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: An evolutionary perspective (2004) (109)
- The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder. (2012) (106)
- Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort (2016) (103)
- Childhood Inattention and Dysphoria and Adult Obesity Associated with the Dopamine D4 receptor Gene in Overeating Women with Seasonal Affective Disorder (2004) (99)
- Course and Outcome after the First Manic Episode in Patients with Bipolar Disorder: Prospective 12-Month Data from the Systematic Treatment Optimization Program for Early Mania Project (2009) (98)
- Divalproex sodium versus placebo in the treatment of acute bipolar depression: a systematic review and meta-analysis. (2010) (98)
- A controlled study of light therapy for bulimia nervosa. (1994) (95)
- Seasonal affective disorder. (1990) (95)
- Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management. (2017) (94)
- A controlled study of light therapy in women with late luteal phase dysphoric disorder (1999) (93)
- Sleep disturbances and depression: a challenge for antidepressants (2006) (93)
- Melatonin suppression in bipolar and unipolar mood disorders (1990) (92)
- Perceived Quality of Life in Patients with Bipolar Disorder. Does Group Psychoeducation Have an Impact? (2005) (91)
- Update on the Biology of Seasonal Affective Disorder (2005) (90)
- Evidence of a Biological Effect of Light Therapy on the Retina of Patients with Seasonal Affective Disorder (2009) (90)
- Citalopram and bupropion-SR: combining versus switching in patients with treatment-resistant depression. (2004) (89)
- The chronotherapeutic treatment of bipolar disorders: A systematic review and practice recommendations from the ISBD task force on chronotherapy and chronobiology (2019) (88)
- Clinical effectiveness: the importance of psychosocial functioning outcomes. (2011) (84)
- Relationship between cognitive functioning and 6-month clinical and functional outcome in patients with first manic episode bipolar I disorder (2010) (83)
- A systematic review and meta-analysis of randomized controlled trials of adjunctive ketamine in electroconvulsive therapy: efficacy and tolerability. (2015) (83)
- Clinical guidelines for the treatment of depressive disorders, I. Definitions, prevalence, and health burden. (2001) (82)
- Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials. (2016) (81)
- Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo‐controlled trial (2010) (80)
- Seasonal depression: the dual vulnerability hypothesis revisited. (2001) (79)
- Effects of rapid tryptophan depletion on brain 5-HT2 receptors: a PET study (2001) (77)
- Depressive symptoms and family history in seasonal and nonseasonal mood disorders. (1993) (77)
- The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive Disorder. (2017) (76)
- Gender differences in the heritability of seasonal mood change (1997) (75)
- PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic mania. (2002) (75)
- Efficacy of Vortioxetine on Cognitive Functioning in Working Patients With Major Depressive Disorder. (2017) (73)
- The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. (2020) (73)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) consensus recommendations for functional outcomes in major depressive disorder. (2015) (72)
- Effect of electroconvulsive therapy on brain 5-HT2 receptors in major depression (2010) (71)
- Side effects of light therapy in seasonal affective disorder. (1993) (70)
- Onset, time course and trajectories of improvement with antidepressants (2012) (69)
- Electroretinography in patients with winter seasonal affective disorder (2004) (69)
- The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response prediction. (2012) (68)
- Assessment Scales in Depression, Mania and Anxiety (2004) (67)
- Treatment of Seasonal Affective Disorder: A Review (1995) (66)
- The Association of Elevated Body Mass Index with Reduced Brain Volumes in First-Episode Mania (2011) (65)
- A controlled trial of the Litebook light-emitting diode (LED) light therapy device for treatment of Seasonal Affective Disorder (SAD) (2007) (65)
- A new clinical rating scale for work absence and productivity: validation in patients with major depressive disorder (2009) (64)
- Using Metaanalysis to Evaluate Evidence: Practical Tips and Traps (2005) (62)
- Early Switching Strategies in Antidepressant Non-Responders: Current Evidence and Future Research Directions (2014) (62)
- Which Depressive Symptoms and Medication Side Effects Are Perceived by Patients as Interfering Most with Occupational Functioning? (2012) (62)
- A magnetic resonance imaging study of mood stabilizer- and neuroleptic-naïve first-episode mania. (2007) (61)
- Medications and other biological treatments (2001) (61)
- Functional outcomes in first-episode patients with bipolar disorder: a prospective study from the Systematic Treatment Optimization Program for Early Mania project. (2009) (61)
- Trajectories of Response to Dorsolateral Prefrontal rTMS in Major Depression: A THREE-D Study. (2019) (60)
- S-adenosyl methionine (SAMe) for depression in adults. (2016) (60)
- Atypical depressive symptoms and clusters in unipolar and bipolar depression (1996) (60)
- Canadian Consensus Guidelines for the Treatment of Seasonal Affective Disorder (1999) (60)
- Neuroprogression and episode recurrence in bipolar I disorder: A study of gray matter volume changes in first‐episode mania and association with clinical outcome (2016) (59)
- Light visor treament for seasonal affective disorder: A multicenter study (1993) (59)
- Pharmacotherapy to sustain the fully remitted state. (2002) (58)
- Machine learning and big data analytics in bipolar disorder: A position paper from the International Society for Bipolar Disorders Big Data Task Force (2019) (58)
- Phototherapy for Depressive Disorders: A Review * (1989) (58)
- Burden of Bipolar Depression (2008) (57)
- Polymorphism of the serotonin-2A receptor gene (HTR2A) associated with childhood attention deficit hyperactivity disorder (ADHD) in adult women with seasonal affective disorder. (2002) (57)
- Electroretinography in seasonal affective disorder (1992) (56)
- Brightening Depression (2004) (56)
- Body Mass Index–Related Regional Gray and White Matter Volume Reductions in First-Episode Mania Patients (2014) (55)
- Low electrooculographic ratios in patients with seasonal affective disorder. (1991) (55)
- Enhancing outcomes in the management of treatment resistant depression: a focus on atypical antipsychotics. (2003) (55)
- Effects of combined pharmacotherapy and psychotherapy for improving work functioning in major depressive disorder (2013) (55)
- Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania. (2001) (54)
- Clinical guidelines for the treatment of depressive disorders. II. Principles of management. (2001) (54)
- A Birth-Season/DRD4 Gene Interaction Predicts Weight Gain and Obesity in Women with Seasonal Affective Disorder: A Seasonal Thrifty Phenotype Hypothesis (2006) (54)
- Atypical depressive symptoms in seasonal and non-seasonal mood disorders. (1997) (53)
- Accelerated age-related decrease in brain-derived neurotrophic factor levels in bipolar disorder. (2009) (53)
- The influence of baseline severity on efficacy of escitalopram and citalopram in the treatment of major depressive disorder: an extended analysis. (2006) (53)
- Mood Disorder Service Genetic Database: morbidity risks for mood disorders in 3,942 first-degree relatives of 671 index cases with single depression, recurrent depression, bipolar I, or bipolar II. (1994) (52)
- Discrepancy between objective and subjective cognition in major depressive disorder (2019) (52)
- Mania, Depression, and Mood Dependent Memory (1997) (51)
- 12‐month longitudinal cognitive functioning in patients recently diagnosed with bipolar disorder (2014) (51)
- Adjunctive ketamine in electroconvulsive therapy: Updated systematic review and meta-analysis (2017) (50)
- The effects of ultraviolet-A wavelengths in light therapy for seasonal depression. (1992) (50)
- Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 Report. (2019) (49)
- Effects of rapid tryptophan depletion in patients with seasonal affective disorder in natural summer remission (2000) (49)
- Long-Term and Preventative Treatment for Seasonal Affective Disorder (2007) (49)
- Morning light therapy for winter depression: predictors of response (1994) (49)
- Immune-inflammatory markers in patients with seasonal affective disorder: effects of light therapy. (2001) (48)
- The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study. (2018) (48)
- Seasonality of symptoms in women with late luteal phase dysphoric disorder. (1997) (48)
- L-Tryptophan Augmentation of Light Therapy in Patients with Seasonal Affective Disorder (1997) (47)
- Seasonal mood symptoms in bulimia nervosa and seasonal affective disorder. (1991) (47)
- Therapeutic Mechanism in Seasonal Affective Disorder: Do Fluoxetine and Light Operate Through Advancing Circadian Phase? (2005) (47)
- Recovery and recurrence following a first episode of mania: a systematic review and meta-analysis of prospectively characterized cohorts. (2015) (47)
- Efficacy of second generation antipsychotics in treating acute mixed episodes in bipolar disorder: a meta-analysis of placebo-controlled trials. (2013) (47)
- The validity of atypical depression in DSM-IV. (1996) (46)
- Lurasidone versus treatment as usual for cognitive impairment in euthymic patients with bipolar I disorder: a randomised, open-label, pilot study. (2017) (45)
- A Birth-Season/DRD4 Gene Interaction Predicts Weight Gain and Obesity in Women with Seasonal Affective Disorder: A Seasonal Thrifty Phenotype Hypothesis (2006) (45)
- Abnormal functional connectivity within resting-state networks is related to rTMS-based therapy effects of treatment resistant depression: A pilot study. (2017) (44)
- Growth hormone response to sumatriptan (5-HT1D agonist) challenge in seasonal affective disorder: Effects of light therapy (1997) (44)
- Effects of Alpha-Methyl-Para-Tyrosine-Induced Catecholamine Depletion in Patients with Seasonal Affective Disorder in Summer Remission (2001) (44)
- Cognitive change in the year after a first manic episode: association between clinical outcome and cognitive performance early in the course of bipolar I disorder. (2014) (43)
- Ultraviolet versus non-ultraviolet light therapy for seasonal affective disorder. (1991) (43)
- Psychometric Validation of Perceived Deficits Questionnaire – Depression (PDQ-D) in Patients with Major Depressive Disorder (MDD) (2013) (43)
- Rapid screening for perceived cognitive impairment in major depressive disorder. (2013) (43)
- Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial (2015) (42)
- Effects of light therapy on suicidal ideation in patients with winter depression. (2000) (42)
- Breaking the Myths: New Treatment Approaches for Chronic Depression (2002) (42)
- Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder (2018) (41)
- Clinical guidelines for the treatment of depressive disorders. III. Psychotherapy. (2001) (41)
- Seasonality of symptoms in anorexia and bulimia nervosa. (1996) (40)
- Evidence-based strategies for achieving and sustaining full remission in depression: focus on metaanalyses. (2004) (40)
- The serotonin transporter promoter repeat length polymorphism, seasonal affective disorder and seasonality (2003) (39)
- The Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis (2017) (39)
- Eating attitudes in seasonal affective disorder and bulimia nervosa. (1993) (39)
- Antidepressant drug studies in the elderly. (1988) (37)
- Bipolar spectrum disorders. New perspectives. (2002) (37)
- Association of peripheral inflammation with body mass index and depressive relapse in bipolar disorder (2016) (35)
- Comparative efficacy of escitalopram in the treatment of major depressive disorder (2011) (35)
- Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). (2010) (35)
- Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement (2018) (35)
- The relationship between seasonal mood change and personality: more apparent than real? (1997) (35)
- Bipolar spectrum disorders (2002) (35)
- Sleep architecture variation: a mediator of metabolic disturbance in individuals with major depressive disorder. (2013) (34)
- Systematic review of neurocognition and occupational functioning in major depressive disorder (2013) (34)
- A Season-of-Birth/DRD4 Interaction Predicts Maximal Body Mass Index in Women with Bulimia Nervosa (2010) (34)
- Cognitive Dysfunction in Major Depressive Disorder: Assessment, Impact, and Management. (2016) (34)
- Light therapy for depressive disorders: indications and efficacy. (1997) (34)
- The impact of childhood trauma on cognitive functioning in patients recently recovered from a first manic episode: data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). (2013) (33)
- The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder (2021) (33)
- The association of weight gain with mood symptoms and functional outcomes following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). (2010) (33)
- Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With Depression (2020) (33)
- Do symptoms of bipolar disorder exhibit seasonal variation? A multisite prospective investigation (2011) (33)
- Cortisol, Hypothermic, and Behavioral Responses to Ipsapirone in Patients with Bipolar Depression and Normal Controls (1998) (32)
- Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder. (2017) (32)
- Generic and health-related quality of life in patients with seasonal and nonseasonal depression (2004) (32)
- Seasonal Affective Disorder—A Canadian Sample (1989) (32)
- Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials (2008) (32)
- Prolactin response to buspirone challenge in the presence of dopaminergic blockade (1995) (31)
- O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. (2006) (31)
- A comparison of open treatment of seasonal major and minor depression with light therapy. (2002) (31)
- Enhanced inflammatory and T-helper-1 type responses but suppressed lymphocyte proliferation in patients with seasonal affective disorder and treated by light therapy. (2015) (31)
- The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocols (2019) (31)
- Is remission of depressive symptoms in primary care a realistic goal? A meta-analysis (2004) (30)
- Our Digital Moment: Innovations and Opportunities in Digital Mental Health Care (2020) (30)
- The relationship between burnout and depressive symptoms in patients with depressive disorders. (2015) (30)
- A positron emission tomography study of the effects of treatment with valproate on brain 5-HT2A receptors in acute mania. (2005) (30)
- Oxcarbazepine in the Treatment of Bipolar Disorder: A Review (2006) (30)
- The relationship between clinical outcomes and quality of life in first‐episode mania: a longitudinal analysis (2013) (29)
- Quality of life in bipolar disorder: towards a dynamic understanding (2017) (29)
- Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the Can-SAD study (2006) (28)
- A pilot study of adherence with light treatment for seasonal affective disorder (2007) (28)
- Ketamine: stimulating antidepressant treatment? (2016) (27)
- High-quality remission: potential benefits of the melatonergic approach for patients with major depressive disorder (2007) (27)
- Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report (2019) (27)
- Major depression, minor depression, and double depression: are they distinct clinical entities? (1996) (27)
- Definitions, prevalence, and health burden (2001) (27)
- Relationship between frontostriatal morphology and executive function deficits in bipolar I disorder following a first manic episode: data from the Systematic Treatment Optimization Program for Early Mania (STOP‐EM) (2013) (26)
- White Matter Indices of Medication Response in Major Depression: A Diffusion Tensor Imaging Study. (2019) (26)
- An open trial of light therapy for women with seasonal affective disorder and comorbid bulimia nervosa. (2001) (26)
- Functional disconnectivity of the hippocampal network and neural correlates of memory impairment in treatment-resistant depression. (2019) (26)
- Mirtazapine for treatment-resistant depression: a preliminary report. (2003) (25)
- Predictors of functional improvement in employed adults with major depressive disorder treated with desvenlafaxine (2014) (25)
- Psychiatric morbidity associated with early clinical diagnosis of Huntington disease in a predictive testing program. (1988) (25)
- Clinical Predictors of Short-Term Outcome in Electroconvulsive Therapy (1999) (25)
- Three‐year longitudinal cognitive functioning in patients recently diagnosed with bipolar disorder (2019) (24)
- “They’re always there”: resident experiences of living with rats in a disadvantaged urban neighbourhood (2019) (24)
- Course and outcome following a first episode of mania: four-year prospective data from the Systematic Treatment Optimization Program (STOP-EM). (2015) (24)
- Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report (2020) (24)
- Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants (2019) (24)
- Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar I disorder (2012) (24)
- The effects of desvenlafaxine on neurocognitive and work functioning in employed outpatients with major depressive disorder. (2016) (24)
- Preferred Features of E-Mental Health Programs for Prevention of Major Depression in Male Workers: Results From a Canadian National Survey (2016) (24)
- Mania precipitated by light therapy for patients with SAD. (1994) (23)
- Selective-serotonin reuptake inhibitors (2012) (23)
- Antidepressants and QTc prolongation. (2013) (23)
- Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis (2010) (23)
- Hypothermic, ACTH, and cortisol responses to ipsapirone in patients with mania and healthy controls. (1999) (23)
- ECT in the Treatment of Mixed Depression and Dementia (1988) (23)
- Structural network integrity of the central executive network is associated with the therapeutic effect of rTMS in treatment resistant depression (2019) (23)
- Relief of chronic or resistant depression (Re-ChORD): a pragmatic, randomized, open-treatment trial of an integrative program intervention for chronic depression. (2010) (23)
- Chronic Schizophrenia and Idiopathic Parkinson's Disease (1993) (22)
- Light Therapy for Patients With Bipolar Depression: Systematic Review and Meta-Analysis of Randomized Controlled Trials (2019) (22)
- Long-term neuropsychological safety of subgenual cingulate gyrus deep brain stimulation for treatment-resistant depression. (2014) (22)
- Personality and seasonal affective disorder: results from the CAN-SAD study. (2006) (22)
- Lower cognitive functioning as a predictor of weight gain in bipolar disorder: a 12‐month study (2017) (22)
- Standardization of electroencephalography for multi-site, multi-platform and multi-investigator studies: insights from the canadian biomarker integration network in depression (2017) (22)
- Neurocognitive Functioning in Overweight and Obese Patients with Bipolar Disorder: Data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM) (2014) (22)
- A Canadian multicenter study of three fixed doses of controlled-release ipsapirone in outpatients with moderate to severe major depression. (1998) (21)
- Weight gain as a predictor of frontal and temporal lobe volume loss in bipolar disorder: A prospective MRI study (2018) (21)
- Implications of Cannabis Legalization on Youth and Young Adults (2018) (21)
- Oxcarbazepine add-on in the treatment of refractory bipolar disorder. (2005) (21)
- Conceptualising the neurobiology of fatigue (2013) (21)
- Effects of Divalproex Sodium on 5-HT1A Receptor Function in Healthy Human Males: Hypothermic, Hormonal, and Behavioral Responses to Ipsapirone (1997) (21)
- Effects of lamotrigine on the 5-HT1A receptor function in healthy human males. (1998) (21)
- Sumatriptan-Induced Growth Hormone Release in Patients with Major Depression, Mania, and Normal Controls (1997) (20)
- Brain serotonin-2 receptors in acute mania (2010) (20)
- Childhood maltreatment and corpus callosum volume in recently diagnosed patients with bipolar I disorder: data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). (2014) (20)
- Effect of Stimulus Intensity on Prolactin and Cortisol Release Induced by Unilateral Electroconvulsive Therapy (1996) (20)
- Selection of cognitive tests for trials of therapeutic agents. (2016) (19)
- Development and implementation of guidelines for the management of depression: a systematic review (2020) (19)
- Quality of Life in Patients with Seasonal Affective Disorder: Summer vs Winter Scores (2005) (19)
- Relationship between body mass index and hippocampal glutamate/glutamine in bipolar disorder. (2016) (19)
- Stability, reliability, and validity of the THINC‐it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteers (2018) (19)
- Cannabidiol as a Treatment for Mood Disorders: A Systematic Review (2019) (19)
- Efficacy of Active vs Sham Intermittent Theta Burst Transcranial Magnetic Stimulation for Patients With Bipolar Depression (2021) (18)
- Comparison of fluoxetine and desipramine in depressed outpatients (1993) (18)
- Early change in reward and punishment sensitivity as a predictor of response to antidepressant treatment for major depressive disorder: a CAN-BIND-1 report (2018) (18)
- Trajectories of body mass index change in first episode of mania: 3-year data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). (2017) (18)
- Quality of life impairment in bipolar disorder (2007) (18)
- Reduced accuracy accompanied by reduced neural activity during the performance of an emotional conflict task by unmedicated patients with major depression: A CAN-BIND fMRI study. (2019) (18)
- Seasonal mood change and personality: an investigation of genetic co-morbidity (1998) (18)
- Diagnosis and body mass index effects on hippocampal volumes and neurochemistry in bipolar disorder (2017) (18)
- Treatment of seasonal affective disorder: Unipolar versus bipolar differences (2004) (18)
- Positron emission tomography study of the effects of tryptophan depletion on brain serotonin(2) receptors in subjects recently remitted from major depression. (2012) (17)
- Revising Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, criteria for the bipolar disorders: Phase I of the AREDOC project (2018) (17)
- Epidemiology and burden (2018) (17)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations (2021) (17)
- The Relevance of an Employee Assistance Program to the Treatment of Workplace Depression (2006) (17)
- Growth hormone response to baclofen in patients with mania: a pilot study (1999) (16)
- Non-linear Entropy Analysis in EEG to Predict Treatment Response to Repetitive Transcranial Magnetic Stimulation in Depression (2018) (16)
- It's more than just a referral: Development of an evidence-informed exercise and depression toolkit (2019) (16)
- Review: The importance of early symptom relief in antidepressant treatment: focus on agomelatine (2010) (16)
- Does the addition of pindolol accelerate the response to electroconvulsive therapy in patients with major depression? A double-blind, placebo-controlled pilot study. (2000) (16)
- Abnormal Functional Connectivity of Frontopolar Subregions in Treatment-Nonresponsive Major Depressive Disorder. (2017) (16)
- Treating Depression Effectively: Applying Clinical Guidelines (2004) (16)
- Beyond Zoonosis: The Mental Health Impacts of Rat Exposure on Impoverished Urban Neighborhoods (2018) (16)
- Does neuroimmune dysfunction mediate seasonal mood changes in winter depression? (2004) (15)
- Improvements in quality of life with desvenlafaxine 50mg/d vs placebo in employed adults with major depressive disorder. (2014) (15)
- Clinical guidelines for depressive disorders. Summary of recommendations relevant to family physicians. (2003) (15)
- Fatigue and occupational functioning in major depressive disorder (2013) (15)
- The role of psychoeducation in the treatment of bipolar disorder: A clinical perspective (2004) (15)
- The association of duration and severity of disease with executive function: Differences between drug-naïve patients with bipolar and unipolar depression. (2018) (14)
- The Depression Inventory Development Workgroup: A Collaborative, Empirically Driven Initiative to Develop a New Assessment Tool for Major Depressive Disorder. (2016) (14)
- Multisite Comparison of MRI Defacing Software Across Multiple Cohorts (2021) (14)
- Pigmentary retinopathy associated with low-dose thioridazine treatment. (1985) (14)
- Structural brain changes in first episode mania with and without psychosis: Data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM) (2018) (13)
- Methodological approaches to situational analysis in global mental health: a scoping review (2019) (13)
- A Longitudinal Study of the Relationships Between Mood Symptoms, Body Mass Index, and Serum Adipokines in Bipolar Disorder. (2017) (13)
- Verbal memory impairment in new onset bipolar disorder: Relationship with frontal and medial temporal morphology (2015) (13)
- The clinical use of EEG in a general psychiatric setting. (1988) (13)
- Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 report (2019) (13)
- Core discrete event simulation model for the evaluation of health care technologies in major depressive disorder. (2014) (13)
- Light therapy for seasonal bulimia. (1989) (13)
- A Community-Based Clinic Survey of Antidepressant Use in Persons with Schizophrenia (1998) (12)
- Hypersomnia and morning light therapy for winter depression (1992) (12)
- Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response (2021) (12)
- The Effects of an E-Mental Health Program and Job Coaching on the Risk of Major Depression and Productivity in Canadian Male Workers: Protocol for a Randomized Controlled Trial (2016) (12)
- Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment. (2019) (12)
- A randomized sham controlled comparison of once vs twice-daily intermittent theta burst stimulation in depression: A Canadian rTMS treatment and biomarker network in depression (CARTBIND) study (2021) (12)
- Potential therapeutic benefits of cannabinoid products in adult psychiatric disorders: A systematic review and meta-analysis of randomised controlled trials. (2021) (12)
- Direct Health Care Costs of Treating Seasonal Affective Disorder: A Comparison of Light Therapy and Fluoxetine (2012) (12)
- A PET study of brain 5-HT2 receptors and their correlation with platelet 5-HT2 receptors in healthy humans (2000) (12)
- Accelerated brain aging in major depressive disorder and antidepressant treatment response: A CAN-BIND report (2021) (11)
- Seasonal Affective Disorder: The Latitude Hypothesis Revisited (2002) (11)
- Predictors of cognitive impairment in treatment-resistant depression. (2020) (11)
- Implementing Measurement-Based Care for Depression: Practical Solutions for Psychiatrists and Primary Care Physicians (2021) (11)
- A Positron Emission Tomography Study of Norepinephrine Transporter Occupancy and Its Correlation with Symptom Response in Depressed Patients Treated with Quetiapine XR (2017) (11)
- Effect of Stimulus Energy on Electroconvulsive Therapy-Induced Prolactin Release. (1993) (11)
- The Effects of Newer Antidepressants on Occupational Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2016) (11)
- Visual QC Protocol for FreeSurfer Cortical Parcellations from Anatomical MRI (2020) (11)
- Association Between Side Effects and Blood microRNA Expression Levels and Their Targeted Pathways in Patients With Major Depressive Disorder Treated by a Selective Serotonin Reuptake Inhibitor, Escitalopram: A CAN-BIND-1 Report (2019) (11)
- Manic reaction after induction of ovulation with gonadotropins. (1998) (11)
- Hard Times and Good Friends: Negative Life Events and Social Support in Patients with Seasonal and Nonseasonal Depression (2004) (10)
- The Role of Dopamine in Seizure-Induced Prolactin Release in Humans. (1992) (10)
- Evidence for the Efficacy of Bright Light Therapy for Bipolar Depression. (2018) (10)
- Subcortical structural volumes in recently remitted first episode mania. (2017) (10)
- Men’s Work-Related Stress and Mental Health: Illustrating the Workings of Masculine Role Norms (2019) (10)
- Telephone-administered cognitive-behavioral therapy for clients with depressive symptoms in an employee assistance program: a pilot study. (2011) (9)
- An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report (2020) (9)
- Effects of chronic lithium treatment on retinal electrophysiologic function (1997) (9)
- Electroconvulsive Therapy - Guidelines for Health Authorities in British Columbia (2000) (9)
- Machine learning in the prediction of depression treatment outcomes: a systematic review and meta-analysis (2021) (9)
- The effect of remission status on work functioning in employed patients treated for major depressive disorder. (2017) (9)
- Divalproex Sodium Attenuates Growth Hormone Response to Baclofen in Healthy Human Males (1998) (8)
- Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 Report. (2020) (8)
- Brain Serotonin 2 Receptors in Major Depression (2015) (8)
- Research Funding of Psychiatric Disorders in Canada: A Snapshot, 1990–1991 * (1994) (8)
- The Prevalence and Impact of Depression in Self-Referred Clients Attending an Employee Assistance Program (2012) (8)
- APEC digital hub for mental health. (2017) (8)
- Lithium vs valproate in the maintenance treatment of bipolar I disorder: A post- hoc analysis of a randomized double-blind placebo-controlled trial (2019) (8)
- Reboxetine: a preliminary report on its use through the Special Access Program. (2002) (7)
- Needs, gaps and opportunities for standard and e-mental health care among at-risk populations in the Asia Pacific in the context of COVID-19: a rapid scoping review (2021) (7)
- Barriers and facilitators to implementing measurement-based care for depression in Shanghai, China: a situational analysis (2021) (7)
- Risperidone adjunctive therapy duration in the maintenance treatment of bipolar I disorder: A post hoc analysis. (2019) (7)
- Increased plasma concentration of imipramine following augmentation with fluvoxamine. (1993) (7)
- Exploring the Effects of Temperament on Gray Matter Volume of Frontal Cortex in Patients with Mood Disorders (2021) (7)
- Psychotherapies, alone and in combination (2007) (7)
- Seasonal Affective Disorder Presenting as Chronic Fatigue Syndrome (1991) (7)
- Probing the clinical and brain structural boundaries of bipolar and major depressive disorder (2021) (7)
- Why are there no treatment guidelines for mood disorders and comorbidities? (2012) (6)
- Efficacy, effectiveness and efficiency of escitalopram in the treatment of major depressive and anxiety disorders (2007) (6)
- A sparse representation-based method for parcellation of the resting brain and its application to treatment-resistant major depressive disorder (2017) (6)
- The Basics of Project Evaluation and Lessons Learned (2018) (6)
- 315. Effects of rapid tryptophan depletion on brain 5-HT2 receptors: a PET study (2000) (6)
- A double‐blind, placebo‐controlled study of adjunctive calcitonin nasal spray in acute refractory mania (2013) (6)
- Research-Track Programs for Residents in Psychiatry: A Review of Literature and a Report of 3 Canadian Experiences (2014) (6)
- Structural covariance pattern abnormalities of insula in major depressive disorder: A CAN-BIND study report (2020) (6)
- A Clinician's Guide to Using Light Therapy (2009) (6)
- The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder (2022) (6)
- Efficacy and tolerability of lisdexamfetamine as an antidepressant augmentation strategy: A meta-analysis of randomized controlled trials. (2018) (6)
- Metabolomic signatures associated with depression and predictors of antidepressant response in humans: A CAN-BIND-1 report (2021) (6)
- ECT‐induced prolactin release: Effect of sex, electrode placement and serotonin uptake inhibition (1991) (6)
- Smartphone‐based interventions in bipolar disorder: Systematic review and meta‐analyses of efficacy. A position paper from the International Society for Bipolar Disorders (ISBD) Big Data Task Force (2022) (6)
- Adverse effects of pindolol augmentation in patients with bipolar depression. (1999) (6)
- Obtaining a Family Psychiatric History: Is it Worth the Effort? (1993) (6)
- Are There Therapeutic Benefits of Cannabinoid Products in Adult Mental Illness? (2020) (5)
- Effect of desvenlafaxine 50 mg and 100 mg on energy and lassitude in patients with major depressive disorder: A pooled analysis (2017) (5)
- Reverse translation of major depressive disorder symptoms: A framework for the behavioural phenotyping of putative biomarkers. (2019) (5)
- Patients' preferences and counselling for depression in primary care (2001) (5)
- The Efficacy of Measurement-Based Care for Depressive Disorders: Systematic Review and Meta-Analysis of Randomized Controlled Trials. (2021) (5)
- Preventing neuroleptic-induced tardive dyskinesia in adults and children. (1988) (5)
- Treating Depression Effectively: Second Edition (2007) (5)
- The impact of fatigue and energy on work functioning and impairment in patients with major depressive disorder treated with desvenlafaxine (2017) (5)
- Request for more information about study of rapid cycling in affective disorders. (1991) (5)
- Seasonal affective disorders (1994) (5)
- Escitalopram ameliorates differences in neural activity between healthy comparison and major depressive disorder groups on an fMRI Emotional conflict task: A CAN-BIND-1 study. (2019) (5)
- Reliability of a functional magnetic resonance imaging task of emotional conflict in healthy participants (2019) (5)
- A comparison of personality function among patients with seasonal depression, nonseasonal depression, and nonclinical participants. (2004) (5)
- STAR*D and Measurement-Based Care for Depression: Don't Toss Out the Baby! (2015) (5)
- The association of weight gain with mood symptoms and functional outcomes following a first manic episode: Prospective 12-month data from the systematic treatment optimization program for early mania (STOP-EM) (2010) (5)
- Treatment of depression in patients with dementia. (1990) (5)
- A Psychiatric Fellowship in the United States * (1990) (5)
- Psychiatric and physical comorbidities in depression (2007) (5)
- P.2.g.008 Extended release quetiapine fumarate monotherapy as maintenance treatment in patients with major depressive disorder (MDD) (2008) (4)
- Appetitive Symptoms Differentially Predict Treatment Response to Fluoxetine, Light, and Placebo in Nonseasonal Major Depression. (2018) (4)
- PRESCRIBING ANTIDEPRESSANTS FOR DEPRESSION IN 2005: RECENT CONCERNS AND RECOMMENDATIONS A Statement for the Canadian Psychiatric Association (2005) (4)
- Evidence Supports Validity of Seasonal Affective Disorder (2002) (4)
- Sinus Tachycardia Induced by Methocarbamol and Repetitive Transcranial Magnetic Stimulation (rTMS) (2016) (4)
- Quality of Life Impacts of Bright Light Treatment, Fluoxetine, and the Combination in Patients with Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial (2020) (4)
- Relationship between work functioning and self-reported cognitive complaints in patients with major depressive disorder treated with desvenlafaxine (2019) (4)
- The Quality of Life in Bipolar Disorder (QoL.BD) questionnaire a decade on - A systematic review of the measurement of condition-specific aspects of quality of life in bipolar-disorder. (2020) (4)
- Exploring brain connectivity changes in major depressive disorder using functional‐structural data fusion: A CAN‐BIND‐1 study (2021) (4)
- Mental Health Service Challenges during the Early Stage of the COVID-19 Pandemic: Experience and Best Practices from China (2020) (4)
- Comprar Treating Depression Effectively: Applying Clinical Guidelines, Second Edition | Michael E. Thase | 9780415439107 | Informa Healthcare (2007) (4)
- Baseline functional connectivity in resting state networks associated with depression and remission status after 16 weeks of pharmacotherapy: A CAN-BIND Report (2021) (4)
- Hypothalamus volume and DNA methylation of stress axis genes in major depressive disorder: A CAN-BIND study report (2021) (4)
- Deep brain stimulation interruption and suicidality. (2012) (3)
- Association of intranasal esketamine, a novel ‘standard of care’ treatment and outcomes in the management of patients with treatment-resistant depression: protocol of a prospective cohort observational study of naturalistic clinical practice (2022) (3)
- Use of Placebo in Clinical Trials of Psychotropic Medication (2018) (3)
- Assessment Scales in Depression and Anxiety - CORPORATE : (Servier Edn) (2006) (3)
- Serum epidermal growth factor, clinical illness course, and limbic brain volumes in early-stage bipolar disorder. (2020) (3)
- Lam employment absence and productivity scale (LEAPS): Further validation studies in major depressive disorder (2014) (3)
- Cognitive Outcomes with Sequential Escitalopram Monotherapy and Adjunctive Aripiprazole Treatment in Major Depressive Disorder: A Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report (2021) (3)
- Challenges in the treatment of anxiety disorders: beyond guidelines (2006) (3)
- Psychosocial Outcomes following Electroconvulsive Therapy in a Community Setting: Retrospective Chart Review with 2-Year Follow-up (2007) (3)
- Do the symptoms of bipolar disorder really show seasonal variation? (2013) (3)
- Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 report (2022) (3)
- Association of total peripheral inflammation with lower frontal and temporal lobe volumes in early-stage bipolar disorder: A proof-of-concept study. (2022) (3)
- THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial. (2020) (2)
- Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response (2021) (2)
- Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND Report (2021) (2)
- Advances in treatment of mood and anxiety disorders: focus on atypical antipsychotics. (2003) (2)
- Review: antidepressants and psychotherapy may be equally effective for promoting remission in major depressive disorder (2003) (2)
- Role of serotonin3 receptors in prolactin release induced by electroconvulsive therapy: A study with ondansetron (1996) (2)
- Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study (2022) (2)
- Re-Examining Seasonal Affective Disorder (2002) (2)
- Solution-Focused Brief Practice with Long-Term Clients in Mental Health Services. "I am More than my Label." (2008) (2)
- Growth hormone response to baclofen in patients with seasonal affective disorder: effects of light therapy (1999) (2)
- A Positron Emission Tomography Study of Dopamine Transporter Density in Patients With Bipolar Disorder With Current Mania and Those With Recently Remitted Mania. (2022) (2)
- Clinical and Functional Characteristics of Cognitive Dysfunction in Major Depressive Disorder (2019) (2)
- Generalized anxiety disorder: how to treat, and for how long? (2006) (2)
- Repeated subcutaneous racemic ketamine in treatment-resistant depression: case series (2022) (2)
- Review: lithium augmentation increases treatment response in refractory depression (2000) (2)
- Blue-Light Therapy for Seasonal and Non-Seasonal Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2022) (2)
- Association between discrepancy in objective and subjective cognitive abilities and treatment response in patients with major depressive disorder: A CAN-BIND-1 study report. (2021) (2)
- The APEC Digital Hub-WONCA Collaborative Framework on Integration of Mental Health into Primary Care in the Asia Pacific (2020) (2)
- White matter microstructure in youth at risk for serious mental illness: A comparative analysis (2021) (2)
- The Canadian Biomarker Integration Network for Depression (CAN-BIND): Looking Deeper into Major Depressive Disorder (2013) (2)
- Cortico-cortical and cortico-striatal resting-state functional connectivity differentially predicts response to 10 Hz rTMS and intermittent TBS to the DLPFC (2017) (2)
- Advancing Implementation Science Measurement for Global Mental Health Research (2022) (2)
- Weight gain as a risk factor for progressive neurochemical abnormalities in first episode mania patients: a longitudinal magnetic resonance spectroscopy study (2021) (1)
- Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1 (2021) (1)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder. (2022) (1)
- L-deprenyl, A Selective MAO-B Inhibitor (1987) (1)
- Antidepressants: Which to Use First? (1992) (1)
- Inclusion of mental health in global economic development (2018) (1)
- P382. Replication of Personalized Relapse Prediction in Patients With Major Depressive Disorder Using Digital Biomarkers (2022) (1)
- Perfectionistic Self-Presentation Scale (2012) (1)
- Design of the theta burst versus high frequency rTMS effectiveness evaluation in depression (THREE-D) non-inferiority trial (2017) (1)
- Midodrine for TCA-induced orthostatic hypotension. (1993) (1)
- Response to commentaries on the Canadian Network for Mood and Anxiety Treatments/International Society for Bipolar Disorders 2013 updated Bipolar Disorder Guidelines (2013) (1)
- Baseline Functional Connectivity in Resting State Networks Associated with Depression and Remission Status after 16 Weeks of Pharmacotherapy: A CAN-BIND Report. (2021) (1)
- MO1 Comprehensive Discrete Event Simulation Model for the Evaluation of Health Care Technologies in Depression (2012) (1)
- Subcutaneous and Intramuscular Parental Ketamine for Treatment of Depression: Clinical Treatment Protocol (2022) (1)
- The Effects of Ketamine on Cognition in Unipolar and Bipolar Depression: A Systematic Review. (2022) (1)
- Corrigendum to “A systematic review and meta-analysis of randomized controlled trials of adjunctive ketamine in electroconvulsive therapy: Efficacy and tolerability” [J Psychiatr Res (2015) 62: 23–30] (2015) (1)
- Evolution of antidepressant agents (2007) (1)
- Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study report (2022) (1)
- Safety and Efficacy of Adjunctive Second-Generation Antidepressant Therapy With A Mood Stabiliser or an Atypical Antipsychotic in Acute Bipolar Depression: Randomised Systematic Review and Meta-Analysis of A Placebo-Controlled Trials. (2021) (1)
- improving work functioning in major depressive disorder Effects of combined pharmacotherapy and psychotherapy for (2013) (1)
- Cognitive Impairment in Major Depressive Disorder: A Case Discussion Illustrating Impact, Assessment, and Management. (2018) (1)
- Author response. (2013) (1)
- The naturalistic trajectory of quality of life in bipolar disorder (2015) (1)
- Seasonal affective disorder and beyond : light treatment for SAD and non-SAD conditions (1998) (1)
- Subjective measures of cognitive dysfunction in major depressive disorder (2016) (1)
- Oxcarbazepine in the treatment of bipolar disorder (2006) (1)
- 405. Growth hormone response to sumatriptan (5-HT1D agonist) challenge in sad: Effects of light therapy (1996) (1)
- Depression (Oxford Psychiatry Library Series) (2008) (1)
- 317. A PET study of brain 5-HT2 receptors and their correlation with platelet 5-HT2 receptors (2000) (1)
- Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report (2021) (1)
- “One Degree of Separation”: A Mixed-Methods Evaluation of Canadian Mental Health Care User and Provider Experiences With Remote Care During COVID-19 (2022) (1)
- Evaluation of a disease-management intervention designed to reduce depression disability. (2011) (1)
- Cognitive Dysfunction in the Workplace: Focus on Depression (2019) (1)
- Priorities in treating depression only (2004) (1)
- Chapter 3 Pathogenesis (2012) (1)
- Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 report. (2022) (1)
- Rhythmicity of sleep and clinical outcomes in major depressive disorder: A CAN-BIND-1 Report (2022) (1)
- Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) Study. (2022) (1)
- The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 Report. (2023) (1)
- Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy (2022) (1)
- Depression Inventory Development Scale (2020) (1)
- Magnetic Resonance Imaging Sequence Identification Using a Metadata Learning Approach (2021) (1)
- Gray matter volume drives the brain age gap in schizophrenia: a SHAP study (2023) (1)
- The Role of Fast or Slow Repetitive Transcranial Magnetic Stimulation in Civilian Post-Traumatic Stress Disorder: A Randomized, Sham-Controlled Trial (2019) (1)
- Baseline Anxiety, and Early Anxiety/Depression Improvement in Anxious Depression Predicts Treatment Outcomes with Escitalopram: A CAN-BIND-1 Study Report. (2021) (1)
- NDT_A_283731 79..90 (2021) (0)
- Response to Letter Regarding CANMAT Recommendations for the Pharmacological Treatment of Late-life Depression (2017) (0)
- vidence of a Biological Effect of Light Therapy on the etina of Patients with Seasonal Affective Disorder (0)
- Ethics in Epidemiologic Studies (1985) (0)
- Best Practices and Benchmarking (2018) (0)
- Health and Quality of Life Outcomes Quality of life in bipolar disorder: A review of the literature (2006) (0)
- A sequenced pharmacotherapy for MDD in 2010 (2010) (0)
- Chapter 5 Clinical management (2012) (0)
- SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants (2023) (0)
- From the Guest Editors. (2016) (0)
- Appendix Sample rating scales (2012) (0)
- Dr. Lam Replies (1990) (0)
- Economic Evaluation Core Discrete Event Simulation Model for the Evaluation of Health Care Technologies in Major Depressive Disorder (2014) (0)
- S124. Impact of CYP2C19 and CYP2D6 Genotypes on Clinical Outcomes and Side Effects in Patients Receiving Escitalopram and Aripiprazole for Major Depression: Results From the Can-Bind Cohort (2019) (0)
- Chronobiological Treatments (2019) (0)
- Satisfaction with Working with Depression Program Questionnaire (2015) (0)
- Comparison of 21 Antidepressants. (2018) (0)
- Functional impact of major depressive disorder in an employee and family assistance program (2010) (0)
- Editorial (2004) (0)
- B2 Complementary and alternative treatments for depression (2010) (0)
- Chapter 8 Somatic treatments (2012) (0)
- 286. Genetic Polymorphism of Brain-Derived Neurotrophic Factor is Related to Antidepressant Efficacy and Treatment-Induced Hippocampal Plasticity in Patients With Major Depressive Disorder: CAN-BIND-1 Study (2023) (0)
- Virtual reality interventions to improve cognitive functioning in adults with major psychiatric disorders: A narrative systematic review (Preprint) (2021) (0)
- Patient Attitudes About Light Therapy and Negative Ion Therapy for Nonseasonal Depression: An Online Survey Study. (2021) (0)
- Environment and Psychopathology (1993) (0)
- WINTER SEASONAL AFFECTIVE DISORDER. AUTHOR'S REPLY (1992) (0)
- Distinct Network Structure of Depression Symptoms Among Responders and Non-Responders To Antidepressants and Placebo (2019) (0)
- COMMENT ON: TREATMENT OF SAD. AUTHORS' REPLY (1996) (0)
- Book Review: Text Books (1988) (0)
- Escitalopram versus duloxetine in patients with major depressive disorder: A pooled analysis of two trials (2008) (0)
- Evidence based antidepressant selection across depressive disorders (2007) (0)
- Sequential pharmacotherapies and treatment-resistant depression (2007) (0)
- Effects of intermittent theta-burst transcranial magnetic stimulation on cognition and hippocampal volumes in bipolar depression (2023) (0)
- Early optimized pharmacological treatment in patients with depression and chronic pain (2022) (0)
- The trajectory of quality of life in bipolar disorder (2015) (0)
- Chapter 2 Epidemiology and burden (2012) (0)
- Neuromodulation and other physical treatments (2007) (0)
- Deep Brain Stimulation for Major Depressive Disorder Resistant to Four or More Treatments: Preliminary Results of a Multicenter Study: 857 (2008) (0)
- Prevalence, burden and diagnosis (2007) (0)
- Chapter 9 Special populations (2012) (0)
- Pre-Treatment Resting-State Functional Connectivity Related to Anhedonia and Anxiety are Associated With Antidepressant Response to Escitalopram and Adjunct Aripiprazole (2020) (0)
- Light and biological rhythms in man: Edited by L. Wetterberg. New York: Pergamon Press, 1993. Price $169.20. 448pp (1995) (0)
- Dr Uher and Colleagues Reply. (2020) (0)
- Circadian clock related polymorphisms and the serotonin transporter promoter in seasonal affective disorder and seasonality (2002) (0)
- Comprar Depression | Raymond W. Lam | 9780199219889 | Oxford University Press (2009) (0)
- Interactions between neuroticism and stressful life events predict response to pharmacotherapy for major depression: A CAN-BIND 1 report. (2021) (0)
- Global Mental Health and Technology (2021) (0)
- Erratum to “Growth hormone to baclofen in patients with seasonal affective disorder: effects of light therapy” [Psychoneuroendocrinology 54(2) pp. 143–153 (1999)] (2000) (0)
- S120. Canadian Biomarker Integration Network in Depression (CAN-BIND): Baseline and Follow up Neurocognitive Mediators of Functioning in Major Depressive Disorder (MDD) (2018) (0)
- Comprar A Clinician's Guide to Using Light Therapy | Raymond W. Lam | 9780521697682 | Cambridge University Press (2009) (0)
- Advances in Treatment Current Treatment Recommendations For Seasonal Affective Disorder (2002) (0)
- Review: lithium augmentation increases treatment response in refractory depression (2000) (0)
- Lessons Learned Scenarios in Real Life (2018) (0)
- 608. Baseline Resting-State fMRI Biomarkers of Depression Response to DLPFC-rTMS: Different Patterns of Functional Connectivity Predict Response to 10 Hz rTMS and Intermittant TBS (2017) (0)
- P0255 - Escitalopram and Duloxetine in the treatment of major depression (2008) (0)
- ORIGINAL RESEARCH Economic Evaluation Core Discrete Event Simulation Model for the Evaluation of Health Care Technologies in Major Depressive Disorder (2014) (0)
- Adjunctive Medication Strategies for Treatment- Resistant Depression (2011) (0)
- Chapter 6 Psychotherapy (2012) (0)
- 308. 5-HT1A receptor function in patients with bipolar depression (1998) (0)
- Barriers and facilitators to technology-enhanced measurement based care for depression among Canadian clinicians and patients: Results of an online survey. (2022) (0)
- Practical issues in using antidepressants (2007) (0)
- Clinical features and diagnosis (2018) (0)
- Values and Preferences Related to Workplace Mental Health Programs and Interventions: An International Survey (2023) (0)
- The course of insomnia symptoms during the acute treatment of major depressive disorder: A CAN-BIND-1 Report (2023) (0)
- 316. Brain 5-HT2 receptors in major depression: a PET study (2000) (0)
- Co-design of a Virtual Reality Cognitive Remediation Program for Depression (bWell-D) With Patient End Users and Clinicians: Qualitative Interview Study Among Patients and Clinicians. (2022) (0)
- Chapter 7 Pharmacotherapy (2012) (0)
- Grey matter change in the year following the first episode of mania: association with clinical outcome (2013) (0)
- AB026. Cross-regional collaboration to promote digital mental health equity in the Asia Pacific in the context of coronavirus disease (COVID-19) (2021) (0)
- Co-design of a Virtual Reality Cognitive Remediation Program for Depression (bWell-D) With Patient End Users and Clinicians: Qualitative Interview Study Among Patients and Clinicians (2023) (0)
- The Effectiveness of Internet-Guided Self-help Interventions to Promote Physical Activity Among Individuals With Depression: Systematic Review (2022) (0)
- ABCB1 gene variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-analysis including results from the CAN-BIND-1 Study. (2023) (0)
- P252. Passive Behavior Sensing Features and Depression Characteristics in a Prospective Relapse Monitoring Study (2022) (0)
- Defining Subtypes of Escitalopram Response Using Resting-State fMRI (2022) (0)
- EFFECTS OF CYP2C19, CYP2D6, AND ABCB1 GENE VARIANTS ON ESCITALOPRAM AND ARIPIPRAZOLE TREATMENT-RELATED SEXUAL SIDE EFFECTS: RESULTS FROM THE CAN-BIND-1 STUDY (2022) (0)
- An Empirical Analysis of Structural Neuroimaging Profiles in a Staging Model of Depression (2022) (0)
- Acute and chronic stress predict anti-depressant treatment outcome and naturalistic course of major depression: A CAN-BIND report. (2022) (0)
- Metabolomic signatures associated with depression and predictors of antidepressant response in humans: A CAN-BIND-1 report (2021) (0)
- Long-term effects of rTMS on the functional brain networks in treatment-resistant depression (2019) (0)
- Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain Disorders (2022) (0)
- Peripheral Inflammation as a Marker of Response to Sequential Pharmacotherapy in Major Depressive Disorder: A CAN-BIND-1 Study (2022) (0)
- Standardization of electroencephalography for multi-site, multi-platform and multi-investigator studies: insights from the canadian biomarker integration network in depression (2017) (0)
- Pain severity and pain interference during major depressive episodes treated with escitalopram and aripiprazole adjunctive therapy: a CAN-BIND-1 report (2022) (0)
- Book Review: Seasonal Affective Disorders and Phototherapy (1991) (0)
- A detailed manual segmentation procedure for the hypothalamus for 3T T1-weighted MRI (2022) (0)
- Biophysical compartment models for single-shell diffusion MRI in the human brain: a model fitting comparison (2021) (0)
- EMBED Phase 2 Study Protocol v.1.4: A Cluster Randomized Controlled Trial of Enhanced versus Standard Measurement-Based Care Implementation for Depression (2021) (0)
- Alterations in the Neural Correlates of Affective Inhibitory Control Following Cognitive Behavioral Therapy for Depression: A Canadian Biomarker Integration Network for Depression (CAN-BIND) Study (2022) (0)
- 225. Follow-On Studies From the THREE-D Trial: Preliminary Clinical and Neuroimaging Findings (2018) (0)
- Books Received (2008) (0)
- Association between the expression of lncRNA BASP-AS1 and volume of right hippocampal tail moderated by episode duration in major depressive disorder: a CAN-BIND 1 report (2021) (0)
- Associated clinical features (2018) (0)
- Response Inhibition and Predicting Response to Pharmacological and Cognitive Behavioral Therapy Treatments for Major Depressive Disorder: A CAN-BIND Study. (2022) (0)
- A prospective naturalistic multisite follow-up of survival times for patients with bipolar disorder treated under CANMAT guidelines (2015) (0)
- Response to 10 Hz rTMS or iTBS to the left DLPFC is associated with increased cortico-striatal connectivity. (2017) (0)
- Evidence-Based Management of Seasonal Affective Disorder (SAD) Clinician Resource Package (2002) (0)
- S0033291721000544jra 3783..3791 (2022) (0)
- 222. Clinical Results From the Theta Burst Versus High Frequency Repetitive Transcranial Magnetic Stimulation Effectiveness Evaluation in Depression (THREE-D) Randomized Non-Inferiority Trial (2018) (0)
- S123. Could Response Inhibition Impairment be a Biomarker of Atypical Depression? Differential Cognitive Impairment Profile in Atypical, Treatment-Resistant Depression (2018) (0)
- Mobile Health Applications for Depression in China: A Systematic Review (2022) (0)
- Cerebello-cerebral Functional Connectivity Networks in Major Depressive Disorder: A CAN-BIND-1 Study Report (2021) (0)
- Complementary, light, sleep deprivation and exercise therapies (2007) (0)
- Functional outcomes with bright light in monotherapy and combined with fluoxetine in patients with major depressive disorder: Results from the LIFE-D trial. (2021) (0)
- Impact of Cognitive Impairment on Functioning in Patients With Depression. (2017) (0)
- Chapter 4 Clinical features and diagnosis (2012) (0)
- F113. Hippocampal Subfield-Specific Sex Differences in Patients With Major Depressive Disorder (2019) (0)
- Depression in late life (2007) (0)
- Rating Short-Term Psychodynamic Therapy for the Canadian Network for Mood and Anxiety Treatments Depression Guidelines (2017) (0)
- Light and antidepressant treatment of seasonal affective disorder (SAD): search for a circadian mechanism of action (2005) (0)
- Association of Serum Vitamin D Levels with Depression in Adults: A Nationwide Population-based Study in Korea. (2020) (0)
- Evidence supports validity of seasonal affective disorder. Author's reply (2002) (0)
- 224. Resting-State fMRI Predictors and Mechanisms of rTMS Treatment Response: Neuroimaging Results of the Three-D Study (2018) (0)
- Neurobiological Aspects of Functional Recovery in Major Depressive Disorder (2019) (0)
- Depression in women (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Raymond W. Lam?
Raymond W. Lam is affiliated with the following schools:
